Neelima Begum

Chief Financial Officer at Y-mAbs Therapeutics - New York, NY, US

Neelima Begum's Contact Details
HQ
646-885-8505
Location
Copenhagen Metropolitan Area
Company
Y-mAbs Therapeutics
Neelima Begum's Company Details
Y-mAbs Therapeutics logo, Y-mAbs Therapeutics contact details

Y-mAbs Therapeutics

New York, NY, US • 100 - 249 Employees
BioTech/Drugs

Y-mAbs is late-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. The Company has a broad and advanced product pipeline, including 2 pivotal-stage product candidates - naxitamab and omburtamab - which target tumors that express GD2 and B7-H3, respectively.Our mission is to become the world leader in developing antibody-based cancer products that address clear unmet needs in pediatric oncology. With the right partnerships and collaboration, we envision expanding our capabilities to treat adults - changing the course of cancer and its outcome.

N/A
Details about Y-mAbs Therapeutics
Frequently Asked Questions about Neelima Begum
Neelima Begum currently works for Y-mAbs Therapeutics.
Neelima Begum's role at Y-mAbs Therapeutics is Chief Financial Officer.
Neelima Begum's email address is ***@ymabs.com. To view Neelima Begum's full email address, please signup to ConnectPlex.
Neelima Begum works in the BioTech/Drugs industry.
Neelima Begum's colleagues at Y-mAbs Therapeutics are Mette Mottlau, Natallia Misuna, Lene Schubert, Marc Lundtang, Jon Førster, Daniel Doktor, Tine Kjeldsen and others.
Neelima Begum's phone number is 646-885-8505
See more information about Neelima Begum